Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the business would contemplate new talks with insurers with regard to the list rates of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://beckettvmbsh.jaiblogs.com/57615896/an-unbiased-view-of-healthcare-news